VTYX - Ventyx Biosciences, Inc.
14
0.020 0.143%
Share volume: 5,448,870
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$13.98
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-06-2025 | |
| Assets | |||||||
| Total Assets | 332.078 M | 309.193 M | 301.100 M | 276.563 M | 253.480 M | 211.465 M | |
| Current Assets | 319.759 M | 256.931 M | 289.408 M | 229.625 M | 242.558 M | 201.094 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 160.684 M | 198.513 M | 213.060 M | 190.062 M | 200.731 M | 160.668 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 141.898 M | 40.925 M | 61.765 M | 27.260 M | 28.076 M | 31.970 M | |
| Total Non-current Assets | 0.000 | 40.261 M | 0.000 | 35.621 M | 0.000 | 0.000 | |
| Property Plant Equipment | 828.000 K | 762.000 K | 703.000 K | 614.000 K | 522.000 K | 501.000 K | |
| Other Assets | 11.491 M | 51.500 M | 10.989 M | 46.324 M | 10.400 M | 9.870 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 332.078 M | 309.193 M | 301.100 M | 276.563 M | 253.480 M | 211.465 M | |
| Total liabilities | 25.082 M | 28.398 M | 22.328 M | 22.518 M | 21.847 M | 20.101 M | |
| Total current liabilities | 14.534 M | 18.104 M | 12.303 M | 12.776 M | 12.394 M | 11.259 M | |
| Accounts Payable | 5.583 M | 6.583 M | 2.286 M | 3.130 M | 2.320 M | 993.000 K | |
| Other liabilities | 10.548 M | 10.294 M | 10.025 M | 9.742 M | 9.453 M | 8.842 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 10.548 M | 10.294 M | 10.025 M | 9.742 M | 9.453 M | 8.842 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 306.996 M | 280.795 M | 278.772 M | 254.045 M | 231.633 M | 191.364 M | |
| Common stock | 764.876 M | 770.752 M | 802.857 M | 808.197 M | 813.228 M | 822.706 M | |
| Retained earnings | -457.759 M | -489.709 M | -524.958 M | -554.309 M | -581.749 M | -631.565 M |